Philip M. Kluin

11.8k citations

130 papers · 6.8k indexed · 2 hit papers · h-index 47

Pathology and Forensic Medicine top 0.2%
Oncology top 1%
Immunology top 1%
Genetics top 0.5%
Molecular Biology top 10%

Co-authors: Ed Schuuring Hanneke C. Kluin‐Nelemans Paul P. Tak Tom Smeets A. Edo Meinders Mohamed R. Daha Gustaaf W. van Imhoff Ferdinand C. Breedveld
Topics: Lymphoma Diagnosis and Treatment (73 papers)Chronic Lymphocytic Leukemia Research (32 papers)Viral-associated cancers and disorders (25 papers)
Cited by: Pathology and Forensic Medicine Genetics Oncology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Netherlands United States Germany

In The Last Decade

Philip M. Kluin

129 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Double-hit B-cell lymphomas

2010 451 citations Ed Schuuring, Gustaaf W. van Imhoff et al. Blood profile →
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

1997 449 citations Paul P. Tak, Tom Smeets et al. profile →

Peers

Countries citing papers authored by Philip M. Kluin

Since Specialization

Citations

This map shows the geographic impact of Philip M. Kluin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Kluin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Kluin more than expected).

Fields of papers citing papers by Philip M. Kluin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip M. Kluin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Kluin. The network helps show where Philip M. Kluin may publish in the future.

Co-authorship network of co-authors of Philip M. Kluin

This figure shows the co-authorship network connecting the top 25 collaborators of Philip M. Kluin. A scholar is included among the top collaborators of Philip M. Kluin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip M. Kluin. Philip M. Kluin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case report of a clinically indolent but morphologically high‐grade cutaneous mast cell tumor in an adult: Atypical cutaneous mastocytoma or mast cell sarcoma? 2021 ·Journal of Cutaneous Pathology ·(unknown),J Oldhoff,Arjan Diepstra,Peter Valent,Hans‐Peter Horny,Hanneke N.G. Oude Elberink,Philip M. Kluin,Gilles F.H. Diercks	2
2	Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study 2011 ·The Journal of Rheumatology ·Rodney Pollard,Justin Pijpe,Hendrika Bootsma,Fred K. L. Spijkervet,Philip M. Kluin,Jan L.N. Roodenburg,Cees G. M. Kallenberg,Arjan Vissink,Gustaaf W. van Imhoff	51
3	Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer 2007 ·Clinical Cancer Research ·Johan H. Gibcus,Lorian Menkema,Mirjam F. Mastik,Mario Hermsen,Geertruida H. de Bock,Marie‐Louise F. van Velthuysen,Robert P. Takes,Klaas Kok,(unknown),Bernard F. A. M. van der Laan,Michiel W. M. van den Brekel,Johannes A. Langendijk,Philip M. Kluin,Jacqueline E. van der Wal,Ed Schuuring	74
4	Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma 2007 ·Journal of Clinical Oncology ·Annuska M. Glas,Laurent Knoops,Leonie Delahaye,Marie José Kersten,Robby E. Kibbelaar,(unknown),Ryan K. van Laar,J. Han van Krieken,Joke W. Baars,John Raemaekers,Philip M. Kluin,Laura van ‘t Veer,Daphne de Jong	197
5	Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma 2006 ·Clinical Cancer Research ·Marije Booman,(unknown),Annuska M. Glas,Sietske A. Riemersma,Ekaterina S. Jordanova,Klaas Kok,Andreas Rosenwald,Daphne de Jong,Ed Schuuring,Philip M. Kluin	53
6	High numbers of tumour‐infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis 2005 ·The Journal of Pathology ·Sietske A. Riemersma,Joost J. Oudejans,(unknown),Enno Dreef,Frans A. Prins,Patty M. Jansen,Maarten H. Vermeer,P Blok,(unknown),Jettie J.F. Muris,Ed Schuuring,Philip M. Kluin	48
7	Early onset post‐transplant lymphoproliferative disease is associated with allograft localization 2005 ·Clinical Transplantation ·Nicolaas A. Bakker,Gustaaf W. van Imhoff,Erik A.M. Verschuuren,Willem J. van Son,Jaap J. Homan van der Heide,Nic J.G.M. Veeger,Philip M. Kluin,Hanneke C. Kluin‐Nelemans	63
8	BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B 2005 ·Genes Chromosomes and Cancer ·Anneke Bosga-Bouwer,Eugenia Haralambieva,Marije Booman,Ronald Boonstra,Anke van den Berg,Ed Schuuring,Eva van den Berg,Philip M. Kluin,Sibrand Poppema	19
9	HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical 2005 ·Transplantation ·Nicolaas A. Bakker,Gustaaf W. van Imhoff,Erik A.M. Verschuuren,Willem J. van Son,Jaap J. Homan van der Heide,(unknown),Nic J.G.M. Veeger,Philip M. Kluin,Hanneke C. Kluin‐Nelemans,Bouke G. Hepkema	31
10	Identification of a novel RAS GTPase‐activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia 2004 ·Genes Chromosomes and Cancer ·Anne R. M. von Bergh,(unknown),Arjan J. Groot,(unknown),J.H. Frederik Falkenburg,Philip M. Kluin,Ed Schuuring	20
11	Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies 2003 ·The Hematology Journal ·Martina Wilke,Harry Dolstra,Frans Maas,Jos Pool,Rolf E. Brouwer,JH Falkenburg,(unknown),Femke Lamers,Ed Schuuring,Philip M. Kluin,Francis Brasseur,Els Goulmy	32
12	SUCCESSFUL OUTCOME WITH A ???QUINTUPLE APPROACH??? OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2001 ·Transplantation ·C. G. Schaar,J.W. van der Pijl,Bart van Hoek,Johan W. de Fijter,Roeland A. Veenendaal,Philip M. Kluin,J. Han van Krieken,Annemarie Hekman,Wim Terpstra,(unknown),Hanneke C. Kluin‐Nelemans	30
13	Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). 2000 ·Blood ·Johannes W.G. Janssen,(unknown),(unknown),Anna Jauch,Philip M. Kluin,(unknown),P. Leif Bergsagel,W. Michael Kuehl,Hans G. Drexler,Takemi Otsuki,Claus R. Bartram,Ed Schuuring	94
14	Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules 1999 ·European Journal of Immunology ·A. Mieke Mommaas,Aat A. Mulder,Reina Jordens,Coby Out,Min Tan,Peter Cresswell,Philip M. Kluin,Frits Koning	41
15	Characterization of the EMS1 Gene and its Product, Human Cortactin 1998 ·Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication ·Ed Schuuring,(unknown),(unknown),Els Verhoeven,Rob Michalides,(unknown),Carla de Boer,Herbert Brok,(unknown),Philip M. Kluin	34
16	INCREASED EXPRESSION OF IL-15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITHYERSINIA-INDUCED ARTHRITIS AND OSTEOARTHRITIS 1997 ·The Journal of Pathology ·(unknown),Ineke M. van der Heijden,Ferdinand C. Breedveld,Tom Smeets,Mohamed R. Daha,Philip M. Kluin,A. Edo Meinders,Paul P. Tak	95
17	Expression of the Activation Antigen CD27 in Rheumatoid Arthritis 1996 ·Clinical Immunology and Immunopathology ·Paul P. Tak,Rogier Q. Hintzen,(unknown),Tom Smeets,Mohamed R. Daha,René A. W. van Lier,Philip M. Kluin,A. Edo Meinders,(unknown),Ferdinand C. Breedveld	53
18	Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignancies 1992 ·Genes Chromosomes and Cancer ·R.E. Kibbelaar,Jan‐Willem R. Mulder,Enno Dreef,Philip M. Kluin,H van Kamp,Hans L. Haak,Anton K. Raap,(unknown),Geoffrey C. Beverstock	12
19	Clinical course and pathologic features of conjunctival non-Hodgkin's lymphoma 1990 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown),(unknown),Philip M. Kluin,Hanneke C. Kluin‐Nelemans,D. de Wolff–Rouendaal	6
20	Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults 1988 ·British Journal of Haematology ·Mariet M. de Planque,Hanneke C. Kluin‐Nelemans,J. Han van Krieken,Philip M. Kluin,Anneke Brand,Geoffrey C. Beverstock,Roel Willemze,Jon J. van Rood	109

About Philip M. Kluin

Philip M. Kluin is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 130 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (73 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Viral-associated cancers and disorders (25 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Genetics (1.5k citations) and Oncology (2.3k citations). Philip M. Kluin has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ed Schuuring, Hanneke C. Kluin‐Nelemans, Paul P. Tak, Tom Smeets, A. Edo Meinders, Mohamed R. Daha, Gustaaf W. van Imhoff, Ferdinand C. Breedveld, Evert-Jan G. Boerma and Ed Schuuring. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact